How Accurately Does Bone Mineral Density Predict Bone Strength? A Clinical Observational Study of Osteoporosis Vertebral Compression Fractures in Postmenopausal Women

Abstract

Objectives: Dual energy x-ray absorptiometry (DXA) provides incomplete information about bone strength. There are few data on the relationship between osteoporosis-related examinations and bone strength. The objective of the present study was to determine which osteoporosis-related examinations best predicted trabecular bone strength, and to enhance a formula for predicting bone strength on the basis of bone density examination.

Methods: This observational study included postmenopausal women (aged over 50 years) who underwent unilateral percutaneous kyphoplasty (PKP) surgery in the lumbar spine between September 2021 and June 2023. The pressure within each balloon expansion circle was extracted to reflect the true bone strength. The NHANES 2013–2014 data were used to assess the performance of the formula. The performance of the formula was compared with that of the observed actual fractures. Bland–Altman analysis was used to compare the agreement between the formula and the fracture risk assessment tool (FRAX) score.

Results: A total of 40 postmenopausal women (mean age ± standard deviation, 70.90 years ± 10.30) were enrolled. The average balloon pressure was 59.23 psi (± 12.40, means ± SDs). The mean BMD of total lumbar spine (average of L1–L4) was 0.89 g/cm² ± 0.20 (mean ± standard), and the Pearson correlation coefficient between lumbar BMD and bone strength was 0.516. After adjusting for age and BMI, the DXA response rate to bone strength reached 72%. Calibration plots of the observed actual fractures versus those estimated via the bone strength formula were considered good fits. The Bland–Altman analysis revealed a nonsignificant difference between the formula and the FRAX score in predicting fracture risk.

Conclusions: After adjustment, the DXA response rate to bone strength reached 72%, indicating a strong correlation. In addition, Bone Strength = DXA × 27 − Age × 0.585-BMI × 0.887 + 98.

Keywords

balloon pressure / bone mineral density (BMD) / bone strength / dual energy x-ray absorptiometry (DXA) / percutaneous kyphoplasty (PKP) surgery

References

[1] G. M. Blake and I. Fogelman, “The Clinical Role of Dual Energy X-Ray Absorptiometry,” European Journal of Radiology 71, no. 3 (2009): 406-414.

[2] S. R. Cummings, D. Bates, and D. M. Black, “Clinical Use of Bone Densitometry: Scientific Review,” Journal of the American Medical Association 288, no. 15 (2002): 1889-1897.

[3] A. A. Khan, R. Slart, D. S. Ali, et al., “Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices,” Mayo Clinic Proceedings 99, no. 7 (2024): 1127-1141.

[4] K. N. Haseltine, T. Chukir, P. J. Smith, J. T. Jacob, J. P. Bilezikian, and A. Farooki, “Bone Mineral Density: Clinical Relevance and Quantitative Assessment,” Journal of Nuclear Medicine 62, no. 4 (2021): 446-454.

[5] C. M. J. de Bakker, W. J. Tseng, Y. Li, H. Zhao, and X. S. Liu, “Clinical Evaluation of Bone Strength and Fracture Risk,” Current Osteoporosis Reports 15, no. 1 (2017): 32-42.

[6] A. A. Licata, “Challenges of Estimating Fracture Risk With DXA: Changing Concepts About Bone Strength and Bone Density,” Aerospace Medicine and Human Performance 86, no. 7 (2015): 628-632.

[7] D. B. Kimmel, R. R. Recker, J. C. Gallagher, A. S. Vaswani, and J. F. Aloia, “A Comparison of Iliac Bone Histomorphometric Data in Post-Menopausal Osteoporotic and Normal Subjects,” Bone and Mineral 11, no. 2 (1990): 217-235.

[8] A. M. Parfitt, C. H. Mathews, A. R. Villanueva, M. Kleerekoper, B. Frame, and D. S. Rao, “Relationships Between Surface, Volume, and Thickness of Iliac Trabecular Bone in Aging and in Osteoporosis. Implications for the Microanatomic and Cellular Mechanisms of Bone Loss,” Journal of Clinical Investigation 72, no. 4 (1983): 1396-1409.

[9] D. Martel, A. Monga, and G. Chang, “Osteoporosis Imaging,” Radiologic Clinics of North America 60, no. 4 (2022): 537-545.

[10] K. Y. Kim and K. M. Kim, “Similarities and Differences Between Bone Quality Parameters, Trabecular Bone Score and Femur Geometry,” PLoS One 17, no. 1 (2022): e0260924.

[11] C. A. Agten, A. J. Ramme, S. Kang, S. Honig, and G. Chang, “Cost-Effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States,” Radiology 285, no. 2 (2017): 506-517.

[12] X. Wen, Y. Zhang, W. Jiang, W. An, B. Zhang, and J. Liu, “Clinical Evaluation of Unilateral Vertebroplasty for OVCF,” Emergency Medicine International 2022 (2022): 2037185.

[13] M. T. Löffler, N. Sollmann, K. Mei, et al., “X-Ray-Based Quantitative Osteoporosis Imaging at the Spine,” Osteoporosis International 31, no. 2 (2020): 233-250.

[14] J. M. Bland and D. G. Altman, “Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement,” Lancet 1, no. 8476 (1986): 307-310.

[15] P. Ammann and R. Rizzoli, “Bone Strength and Its Determinants,” Osteoporosis International 14, no. Suppl 3 (2003): S13-S18.

[16] C. Poiana, R. Dusceac, and D. A. Niculescu, “Utility of Trabecular Bone Score (TBS) in Bone Quality and Fracture Risk Assessment in Patients on Maintenance Dialysis,” Frontiers in Medicine 8 (2021): 782837.

[17] J. P. Roux, J. Wegrzyn, S. Boutroy, M. L. Bouxsein, D. Hans, and R. Chapurlat, “The Predictive Value of Trabecular Bone Score (TBS) on Whole Lumbar Vertebrae Mechanics: An Ex Vivo Study,” Osteoporosis International 24, no. 9 (2013): 2455-2460.

[18] R. L. Barron, G. Oster, A. Grauer, D. B. Crittenden, and D. Weycker, “Determinants of Imminent Fracture Risk in Postmenopausal Women With Osteoporosis,” Osteoporosis International 31, no. 11 (2020): 2103-2111.

[19] D. M. Black and C. J. Rosen, “Clinical Practice Postmenopausal Osteoporosis,” New England Journal of Medicine 374, no. 3 (2016): 254-262.

[20] R. Eastell and P. Szulc, “Use of Bone Turnover Markers in Postmenopausal Osteoporosis,” Lancet Diabetes and Endocrinology 5, no. 11 (2017): 908-923.

[21] J. P. Brown, A. Don-Wauchope, P. Douville, C. Albert, and S. D. Vasikaran, “Current Use of Bone Turnover Markers in the Management of Osteoporosis,” Clinical Biochemistry 109-110 (2022): 1-10.

[22] K. K. Ivaska, F. E. McGuigan, L. Malmgren, et al., “Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk From Age 75 to 90,” Calcified Tissue International 111, no. 3 (2022): 288-299.

[23] I. R. Reid, “Fat and Bone,” Archives of Biochemistry and Biophysics 503, no. 1 (2010): 20-27.

[24] T. J. Beck, M. A. Petit, G. Wu, M. S. LeBoff, J. A. Cauley, and Z. Chen, “Does Obesity Really Make the Femur Stronger? BMD, Geometry, and Fracture Incidence in the Women's Health Initiative-Observational Study,” Journal of Bone and Mineral Research 24, no. 8 (2009): 1369-1379.

[25] R. Korpelainen, J. Korpelainen, J. Heikkinen, K. Väänänen, and S. Keinänen-Kiukaanniemi, “Lifelong Risk Factors for Osteoporosis and Fractures in Elderly Women With Low Body Mass Index—A Population-Based Study,” Bone 39, no. 2 (2006): 385-391.

[26] P. Dargent-Molina, F. Poitiers, and G. Bréart, “In Elderly Women Weight Is the Best Predictor of a Very Low Bone Mineral Density: Evidence From the EPIDOS Study,” Osteoporosis International 11, no. 10 (2000): 881-888.

[27] J. A. Morris, J. P. Kemp, S. E. Youlten, et al., “An Atlas of Genetic Influences on Osteoporosis in Humans and Mice,” Nature Genetics 51, no. 2 (2019): 258-266.

[28] J. A. Kanis, “Diagnosis of Osteoporosis and Assessment of Fracture Risk,” Lancet 359, no. 9321 (2002): 1929-1936.

[29] A. Chandra and J. Rajawat, “Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics,” International Journal of Molecular Sciences 22, no. 7 (2021): 3553.

RIGHTS & PERMISSIONS

2025 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.